Michaela Novakova

McDermott Will & Emery

Contact
View Bio
RSS

Latest Posts › Regulatory Agenda

Share:

Lowest-risk Clinical Trials Will Benefit From a New Notification Scheme and a Shorter Period for Application Processing

On 12 October 2023, the Medicines and Healthcare products Regulatory Agency (the MHRA) announced that the healthcare and life sciences sector will benefit from a new streamlined notification scheme for lowest-risk clinical...more

10/30/2023  /  Clinical Trials , EU , Life Sciences , Medicines and Healthcare Products Regulatory Agency (MHRA) , Pharmaceutical Industry , Prescription Drugs , Regulatory Agenda , Regulatory Standards , UK

Great Britain and European Union Timelines: What Are the Key Dates for Transition?

The Medicines and Healthcare products Regulatory Agency (MHRA) recently published long-awaited guidance confirming that there will be a delay in the implementation of new legislation for the Great Britain market and an...more

6/2/2023  /  EU , Life Sciences , Medical Devices , Medicines and Healthcare Products Regulatory Agency (MHRA) , Pharmaceutical Industry , Regulatory Agenda , UK , UK Brexit
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide